Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,758
Closed -$929K 424
2024
Q3
$929K Buy
29,758
+208
+0.7% +$5.17K 0.45% 5
2024
Q2
$459K Buy
29,550
+19,266
+187% +$233K 0.24% 66
2024
Q1
$109K Buy
+10,284
New +$103K 0.04% 477
2023
Q3
Sell
-14,527
Closed -$123K 433
2023
Q2
$123K Buy
+14,527
New +$121K 0.06% 388

Other funds holding CDNA

Corton Capital's CDNA Position: Q4 2024 in Review

Corton Capital sold out of CareDx (CDNA) in Q4 2024, closing a stake of 29,758 shares — an estimated $929K sold.

Corton Capital first reported a position in CDNA in Q2 2023 and held it in 4 quarters. The position peaked at $929K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Corton Capital reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 29,758 CareDx shares in Q4 2024, an estimated $929K.
  • Corton Capital first reported a position in CareDx in Q2 2023 and held it in 4 quarters.
  • Corton Capital's CareDx position peaked at $929K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.